Ocuphire Pharma Net Profit Margin 2010-2024 | IRD
Ocuphire Pharma net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Ocuphire Pharma Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-06-30 |
$0.02B |
$-0.01B |
-82.35% |
| 2024-03-31 |
$0.02B |
$-0.01B |
-55.00% |
| 2023-12-31 |
$0.02B |
$-0.01B |
-50.00% |
| 2010-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2010-03-31 |
$0.00B |
$-0.01B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
|
|
$0.000B |
$0.000B |
|
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
|
